NFE2L2 and early-onset autosomal dominant Alzheimer disease: In a recent study, Kim et al. reported that sodium butyrate promoted inactivation of the nuclear factor kappa-B (NF-κB) pathway through the Nrf2 pathway, upregulated SOD levels, and inhibited Nox2 expression in a mouse Alzheimer's disease model [32].